-
Regulus Therapeutics Inc. (NASDAQ:RGLS) Receives Average Rating of "Moderate Buy" from Brokerages
Source: Buzz FX / 03 Mar 2025 02:36:13 America/New_York
Regulus Therapeutics Inc. (NASDAQ:RGLS) Receives Average Rating of "Moderate Buy" from Brokerages Written by MarketBeat March 3, 2025 Share Link copied to clipboard. Shares of Regulus Therapeutics Inc.
Read more...